Alamar CFO granted RSUs and options, no open trades

Alamar Biosciences Chief Financial Officer Justin J. McAnear reported new equity awards and an option restructuring.

Rhea-AI Filing Summary

Alamar Biosciences Chief Financial Officer Justin J. McAnear reported new equity awards and an option restructuring. He received 37,220 shares of Common Stock as restricted stock units that vest monthly from the grant date, conditioned on his continued service.

He was also granted stock options for 163,358 shares of Common Stock at an exercise price of $17.00 per share, with 25% vesting on April 16, 2027 and the remainder vesting in equal monthly installments thereafter, subject to continued service. In addition, 570,719 stock options with a $4.62 exercise price were reclassified so the underlying security changed from Class B Common Stock to Common Stock in connection with the company’s initial public offering, with no open-market buying or selling reported.

Insights

Equity compensation analyst

CFO received routine equity grants and an option reclassification, with no open‑market trades.

The filing shows equity-based compensation rather than discretionary stock purchases or sales. The CFO received 37,220 restricted stock units and 163,358 stock options at a $17.00 exercise price, both vesting over time based on continued service.

Two larger option positions for 570,719 shares at a $4.62 exercise price were reclassified from Class B Common Stock to Common Stock tied to the initial public offering. This J‑code restructuring changes the share class label but not the economic exposure. Overall, these are standard incentive and structural entries, not strong trading signals.

Insider Trade Summary

4 transactions reported

Mixed 4 txns

Insider McAnear Justin J.

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Other	Stock Option (Right to Buy)	570,719	$0.00	$0.00
Other	Stock Option (Right to Buy)	570,719	$0.00	$0.00
Grant/Award	Common Stock	37,220	$0.00	$0.00
Grant/Award	Stock Option (Right to Buy)	163,358	$0.00	$0.00

Holdings After Transaction: Stock Option (Right to Buy) — 734,077 contracts (Direct); Common Stock — 37,220 shares (Direct)

Footnotes (4)

1. F1. Represents the grant of restricted stock units ("RSUs"). The RSUs vest monthly from the date of grant, subject to the reporting person's continuous service as of each such vesting date.
2. F2. Twenty-five percent of the shares subject to the option vest on April 16, 2027, and 1/48th of the shares vest monthly thereafter, subject to the reporting person's continuous service as of each such vesting date.
3. F3. Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the initial public offering of the Issuer's Common Stock.
4. F4. Twenty-five percent of the shares subject to the option vest on October 13, 2026, and 1/48th of the shares vest monthly thereafter, subject to the reporting person's continuous service through each such vesting date.

Key Figures

RSU grant: 37,220 shares New stock options: 163,358 shares at $17.00 Reclassified options: 570,719 shares at $4.62 +3 more

6 metrics

RSU grant 37,220 shares Restricted stock units of Common Stock, vesting monthly from grant date

New stock options 163,358 shares at $17.00 Options on Common Stock, 25% vest on April 16, 2027; remainder monthly

Reclassified options 570,719 shares at $4.62 Options reclassified from Class B Common Stock to Common Stock

Option expiration October 14, 2035 Expiration date for 570,719-share option grant at $4.62

Option expiration April 15, 2036 Expiration date for 163,358-share option grant at $17.00

Restructuring shares total 1,141,438 shares Shares affected by J-code restructuring transactions in the filing

Key Terms

restricted stock units ("RSUs"), Stock Option (Right to Buy), Class B Common Stock, initial public offering, +1 more

5 terms

restricted stock units ("RSUs") financial

"Represents the grant of restricted stock units ("RSUs"). The RSUs vest monthly"

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

Stock Option (Right to Buy) financial

"security_title: "Stock Option (Right to Buy)""

Class B Common Stock financial

"Each share of Class B Common Stock was reclassified into one share"

A class B common stock is one of multiple types of a company’s ordinary shares that carries specific rights—often different voting power or dividend priority—compared with other classes. For investors it matters because those differences affect how much influence you have over company decisions, the income you might receive, and how freely the shares trade; think of it like owning a car with different keys: some keys let you start the engine and open the trunk, others only unlock the door.

initial public offering financial

"immediately prior to the completion of the initial public offering"

An initial public offering (IPO) is when a private company first sells its shares to the public and becomes a stock-listed company. It matters because it allows the company to raise money from a wide range of investors, helping it grow, while giving early shareholders a way to sell some of their ownership.

vesting financial

"Twenty-five percent of the shares subject to the option vest on April 16, 2027"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What equity awards did Alamar Biosciences (ALMR) CFO Justin McAnear receive?

Justin McAnear received 37,220 restricted stock units and 163,358 stock options. The options have a $17.00 exercise price and vest over time, aligning his compensation with Alamar Biosciences’ long‑term performance and his continued employment at the company.

How do Justin McAnear’s new RSUs at Alamar Biosciences (ALMR) vest?

The 37,220 restricted stock units vest monthly starting from the grant date. Each monthly tranche requires Justin McAnear’s continuous service with Alamar Biosciences, turning unvested RSUs into fully owned Common Stock over time as service conditions are met.

What are the terms of the new stock options granted to the ALMR CFO?

McAnear’s new options cover 163,358 shares of Common Stock at a $17.00 exercise price. Twenty‑five percent vest on April 16, 2027, and the remaining 75% vest in equal monthly installments thereafter, contingent on his continued service with Alamar Biosciences.

What is the significance of the 570,719 ALMR stock options with a $4.62 exercise price?

The filing shows 570,719 stock options with a $4.62 exercise price whose underlying security changed from Class B Common Stock to Common Stock. This J‑code transaction reflects a reclassification tied to Alamar Biosciences’ IPO, not an open‑market trade.

Did the Alamar Biosciences (ALMR) CFO buy or sell shares on the open market?

No open‑market purchases or sales are reported. The Form 4 shows equity awards and an internal reclassification of existing stock options, meaning McAnear’s reported activity reflects compensation and structural adjustments rather than discretionary trading decisions.

How do the vesting schedules affect the ALMR CFO’s equity incentives?

Both the RSUs and stock options vest over time, requiring ongoing service. Monthly vesting and initial 25% cliffs for options create long‑term retention incentives, encouraging the CFO to remain at Alamar Biosciences and focus on sustained company performance.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/20/2026 - 08:33 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

McAnear Justin J.

(Last) (First) (Middle)

C/O ALAMAR BIOSCIENCES, INC.

47071 BAYSIDE PARKWAY

(Street)

FREMONT CALIFORNIA 94538

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Alamar Biosciences, Inc. [ ALMR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/20/2026		A(1)		37,220	A	$0	37,220	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$17	04/16/2026		A		163,358		(2)	04/15/2036	Common Stock	163,358	$0	163,358	D
Stock Option (Right to Buy)	$4.62	04/20/2026		J(3)			570,719	(4)	10/14/2035	Class B Common Stock	570,719	$0	0	D
Stock Option (Right to Buy)	$4.62	04/20/2026		J(3)		570,719		(4)	10/14/2035	Common Stock	570,719	$0	570,719	D

Explanation of Responses:

1. Represents the grant of restricted stock units ("RSUs"). The RSUs vest monthly from the date of grant, subject to the reporting person's continuous service as of each such vesting date.

2. Twenty-five percent of the shares subject to the option vest on April 16, 2027, and 1/48th of the shares vest monthly thereafter, subject to the reporting person's continuous service as of each such vesting date.

3. Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the initial public offering of the Issuer's Common Stock.

4. Twenty-five percent of the shares subject to the option vest on October 13, 2026, and 1/48th of the shares vest monthly thereafter, subject to the reporting person's continuous service through each such vesting date.

	/s/ Timothy White, Attorney-in-Fact	04/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)